期刊文献+

大肠癌肝转移的外科治疗 被引量:1

SURGICAL TREATMENT FOR HEPATIC METASTASES FROM LARGE BOWEL CARCINOMA
下载PDF
导出
摘要 目的探讨大肠癌肝转移的手术治疗效果。方法对30例大肠癌肝转移病人施行手术切除,结合文献对手术适应证、手术方式以及随访结果进行分析。结果全组无手术死亡。中位生存期25.6个月,1、3、5年生存率分别为89.3%、41.8%和14.5%。结论早期诊断及手术切除是治疗大肠癌肝转移的有效方法。 Objective To observe the effect of surgical treatment for hepatic metastases from large bowel carcinoma. Methods 30 cases with hepatic metastases from large bowel carcinoma received surgical resection. We reviewed the literature and analyzed the surgical indications, operating modes and follow up results. Results All cases recovered smoothly after operation. The median survival time was 25.6 months. 1 、3、5 year survival rate were 89. 3%, 41.8% and 14. 5% respectively. Conclusion Early diagnosis and surgical resection are the best methods for hepatic metastases from large bowel carcinoma.
出处 《肝胆外科杂志》 2006年第6期428-429,共2页 Journal of Hepatobiliary Surgery
关键词 大肠癌 肝转移 外科手术 large bowel carcinoma hepatic metastases surgery operation
  • 相关文献

参考文献9

  • 1万德森.提高对结直肠癌肝转移的诊治水平[J].实用肿瘤杂志,2003,18(2):80-83. 被引量:8
  • 2吕新生,邱氟,詹勇强.结直肠癌肝转移[J].中国普通外科杂志,2003,12(11):801-803. 被引量:17
  • 3季加孚.结直肠癌肝转移的治疗策略[J].中国实用外科杂志,2004,24(7):398-400. 被引量:26
  • 4Lyass S,Zamir G,Matot I,et al.Combined colon and hepatic resection for synchronous colorectal liver metastases[J].J Surg Oncol,2001,78(1):17 -21.
  • 5蔡成机.大肠癌肝转移的预测[J].腹部外科,2003,16(1):10-11. 被引量:12
  • 6Rees M,John TG.Current status of surgery in colorectal metastases to the liver[J].Hepatogastroenterology,2001,48(38):341-344.
  • 7Lise M,Bacchetti S,Da-Pian P,et al.Patterns of recurrence after resection of colorectal liver metastases:prediction by models of outcome analysis[J].World J Surg,2001,25(5):638 -644.
  • 8Yamada H,Katoh H,Kondo S,et al.Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer[J].Hepatogastroenterology,2001,48(38):828 -830.
  • 9Figueras J,Valls S,Rafecas A,et al.Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases[J].Br J Surg,2001,88(9):980 -985.

二级参考文献12

  • 1Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg, 2003, 197(2): 233-291
  • 2Wagner JS, Adson MA, Van Heerden JA, et al. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg, 1984, 199(5): 502-508
  • 3Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy--an intergroup study. J Clin Oncol,
  • 4Van Cutsem E, Twelves C, Cassidy J, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol, 2001, 19(21): 4097-4106
  • 5Schuller J, Cassidy J, Dumont E, et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol, 2000, 45(4): 291-297
  • 6Rougier P, Van Cutsem E, Bajetta E, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet, 1998, 352(9138): 1407-1412
  • 7Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet, 1998, 352(9138): 1413-1418
  • 8Freyer G, Rougier P, Bugat R, et al. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 a
  • 9Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med, 2000, 343(13): 905-914
  • 10de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer, 1997, 33(2): 214-219

共引文献55

同被引文献49

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部